| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Rubin Steven D (Director) has filed a Form 4 on ChromaDex Corp.|
Txns:
| Granted 20,000 options to buy
@ $1.67, valued at
$33.4k
|
|
| 05/19/2023 |
4
| Rubin Steven D (Executive VP-Administration) has filed a Form 4 on OPKO HEALTH, INC.|
Txns:
| Granted 700,000 options to buy
@ $1.58, valued at
$1.1M
|
|
| 01/31/2023 |
4
| Rubin Steven D (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 2,859 options to buy
@ $4, valued at
$11.4k
|
|
| 10/13/2022 |
4
| Rubin Steven D (Director) has filed a Form 4 on Red Violet, Inc.|
Txns:
| Granted 10,800 shares
@ $0 |
|
| 08/03/2022 |
4
| Rubin Steven D (Director) has filed a Form 4 on Cocrystal Pharma, Inc.|
Txns:
| Granted 188,000 options to buy
@ $0.42, valued at
$79k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2021 |
4
| Rubin Steven D (Director) has filed a Form 4 on Red Violet, Inc.|
Txns:
| Granted 8,900 shares
@ $0 |
|
| 07/20/2021 |
4
| Rubin Steven D (Director) has filed a Form 4 on Cocrystal Pharma, Inc.|
Txns:
| Granted 88,000 options to buy
@ $1.11, valued at
$97.7k
|
|
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2020 |
4
| Rubin Steven D (Director) has filed a Form 4 on Red Violet, Inc.|
Txns:
| Granted 7,000 shares
@ $0 |
|
| 08/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2020 |
4
| Rubin Steven D (Director) has filed a Form 4 on Cocrystal Pharma, Inc.|
Txns:
| Granted 72,000 options to buy
@ $1.33, valued at
$95.8k
|
|
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| Rubin Steven D (Executive VP-Administration) has filed a Form 4 on Opko Health, Inc.|
Txns:
| Granted 350,000 options to buy
@ $2.27, valued at
$794.5k
|
|
| 05/26/2020 |
4
| Rubin Steven D (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $3.39, valued at
$67.8k
|
|
| 10/30/2019 |
4
| Rubin Steven D (Director) has filed a Form 4 on Red Violet, Inc.|
Txns:
| Granted 12,500 shares
@ $0 |
|
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/09/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Rubin Steven D (Executive VP-Administration) has filed a Form 4 on Opko Health, Inc.|
Txns:
| Granted 250,000 options to buy
@ $2.47, valued at
$617.5k
|
|
| 06/24/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/29/2019 |
4
| Rubin Steven D (Director) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.02, valued at
$180.4k
|
|
| 05/10/2019 |
4
| Rubin Steven D (Executive VP-Administration) has filed a Form 4 on Opko Health, Inc.|
Txns:
| Bought 200 shares
@ $2.12, valued at
$424
Bought 2,600 shares
@ $2.13, valued at
$5.5k
Bought 7,200 shares
@ $2.15, valued at
$15.5k
|
|
| 03/07/2019 |
4
| Rubin Steven D (Executive VP-Administration) has filed a Form 4 on Opko Health, Inc.|
Txns:
| Bought 5,565 shares
@ $2.555, valued at
$14.2k
Bought 2,435 shares
@ $2.56, valued at
$6.2k
|
|
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2019 |
4
| Rubin Steven D (Director) has filed a Form 4 on Castle Brands Inc|
Txns:
| Exercised 100,000 options to buy
@ $0.23, valued at
$23k
|
|
| 09/24/2018 |
4
| Rubin Steven D (Director) has filed a Form 4 on Cocrystal Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $2.78, valued at
$139k
|
|
| 06/26/2018 |
4
| Rubin Steven D (Director) has filed a Form 4 on ChromaDex Corp.|
Txns:
| Granted 20,000 options to buy
@ $3.83, valued at
$76.6k
|
|
|